These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 31222775

  • 1. Implementation of a patient blood management program in hematopoietic stem cell transplantation (Editorial, p. 2763).
    Warner MA, Jambhekar NS, Saadeh S, Jacob EK, Kreuter JD, Mundell WC, Marquez A, Higgins AA, Madde NR, Hogan WJ, Kor DJ.
    Transfusion; 2019 Sep; 59(9):2840-2848. PubMed ID: 31222775
    [Abstract] [Full Text] [Related]

  • 2. Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program.
    Leahy MF, Trentino KM, May C, Swain SG, Chuah H, Farmer SL.
    Transfusion; 2017 Sep; 57(9):2189-2196. PubMed ID: 28671296
    [Abstract] [Full Text] [Related]

  • 3. The association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantation.
    Vande Vusse LK, Madtes DK, Guthrie KA, Gernsheimer TB, Curtis JR, Watkins TR.
    Transfusion; 2014 Apr; 54(4):1071-80. PubMed ID: 24033082
    [Abstract] [Full Text] [Related]

  • 4. Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
    Hosoba S, Waller EK, Shenvi N, Graiser M, Easley KA, Al-Kadhimi Z, Andoh A, Antun AG, Barclay S, Josephson CD, Koff JL, Khoury HJ, Langston AA, Zimring JC, Roback JD, Giver CR.
    Biol Blood Marrow Transplant; 2018 May; 24(5):973-982. PubMed ID: 29307717
    [Abstract] [Full Text] [Related]

  • 5. Red blood cell and platelet transfusion support in the first 30 and 100 days after allogeneic hematopoietic cell transplant.
    Yuan S, Yang D, Nakamura R, Zhuang L, Al Malki MM, Karanes C, Wang S.
    Transfusion; 2020 Oct; 60(10):2225-2242. PubMed ID: 32743866
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Relative impact of a patient blood management program on utilization of all three major blood components.
    Thakkar RN, Lee KH, Ness PM, Wintermeyer TL, Johnson DJ, Liu E, Rajprasad A, Knight AM, Wachter PA, Demski R, Frank SM.
    Transfusion; 2016 Sep; 56(9):2212-20. PubMed ID: 27383581
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Red blood cell product utilization in patients undergoing allogeneic stem cell transplantation.
    Gastecki K, Shanley R, Welbig J, Cohn C, Brunstein CG.
    Transfusion; 2019 Jul; 59(7):2301-2307. PubMed ID: 30957250
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Changes in blood product utilization in a seven-hospital system after the implementation of a patient blood management program: A 9-year follow-up.
    Verdecchia NM, Wisniewski MK, Waters JH, Triulzi DJ, Alarcon LH, Yazer MH.
    Hematology; 2016 Sep; 21(8):490-9. PubMed ID: 26870887
    [Abstract] [Full Text] [Related]

  • 12. Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals.
    Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, Hamdorf J, Gallagher T, Koay A, Geelhoed GC, Farmer SL.
    Transfusion; 2017 Jun; 57(6):1347-1358. PubMed ID: 28150313
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Patient blood management in cardiac surgery results in fewer transfusions and better outcome.
    Gross I, Seifert B, Hofmann A, Spahn DR.
    Transfusion; 2015 May; 55(5):1075-81. PubMed ID: 25565302
    [Abstract] [Full Text] [Related]

  • 18. Pre-transplant thrombocytopenia predicts engraftment time and blood products requirement in allogeneic hematopoietic stem cell transplantation patients.
    Roshandel E, Kaviani S, Hajifathali A, Soleimani M.
    Transfus Apher Sci; 2020 Aug; 59(4):102810. PubMed ID: 32430259
    [Abstract] [Full Text] [Related]

  • 19. Lack of RBC transfusion independence by Day 30 following allogeneic hematopoietic stem cell transplant strongly predicts inferior survival and high non-relapse mortality in acute myeloid leukemia patients.
    Yuan S, Yang D, Nakamura R, Al Malki MM, Salhotra A, Afkhami M, Wang S.
    Transfusion; 2024 Feb; 64(2):255-280. PubMed ID: 38225215
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.